Omnicell (OMCL) Competitors

Omnicell (NASDAQ:OMCL) and HealthStream (NASDAQ:HSTM) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, community ranking, risk and analyst recommendations.

Does the MarketBeat Community believe in OMCL or HSTM?

Omnicell received 39 more outperform votes than HealthStream when rated by MarketBeat users. Likewise, 66.84% of users gave Omnicell an outperform vote while only 66.52% of users gave HealthStream an outperform vote.

Company	Underperform	Outperform
Omnicell	Outperform Votes 502 66.84%	Underperform Votes 249 33.16%
HealthStream	Outperform Votes 463 66.52%	Underperform Votes 233 33.48%

Is OMCL or HSTM more profitable?

HealthStream has a net margin of 6.84% compared to Omnicell's net margin of 1.13%. HealthStream's return on equity of 5.67% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omnicell	1.13%	3.82%	2.07%
HealthStream	6.84%	5.67%	3.91%

Does the media favor OMCL or HSTM?

In the previous week, Omnicell had 5 more articles in the media than HealthStream. MarketBeat recorded 11 mentions for Omnicell and 6 mentions for HealthStream. HealthStream's average media sentiment score of 1.34 beat Omnicell's score of 1.03 indicating that HealthStream is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omnicell	6 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthStream	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, OMCL or HSTM?

Omnicell has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Comparatively, HealthStream has a beta of 0.42, suggesting that its stock price is 58% less volatile than the S&P 500.

Which has higher earnings and valuation, OMCL or HSTM?

HealthStream has lower revenue, but higher earnings than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.11B	1.32	$12.53M	$0.27	116.11
HealthStream	$291.65M	3.42	$15.21M	$0.66	49.55

Do insiders & institutionals have more ownership in OMCL or HSTM?

97.7% of Omnicell shares are held by institutional investors. Comparatively, 69.6% of HealthStream shares are held by institutional investors. 2.6% of Omnicell shares are held by insiders. Comparatively, 20.6% of HealthStream shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Do analysts rate OMCL or HSTM?

Omnicell presently has a consensus target price of $51.00, suggesting a potential upside of 62.68%. HealthStream has a consensus target price of $32.00, suggesting a potential downside of 2.14%. Given Omnicell's higher probable upside, equities research analysts plainly believe Omnicell is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
HealthStream	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80

Summary

HealthStream beats Omnicell on 10 of the 18 factors compared between the two stocks.